Skip to main content

Advertisement

ADVERTISEMENT

News

News
10/01/2020
In a systematic review of the worldwide published data on "Venous thromboembolism (VTE) in COVID-19 patients”, Cihan Ay, Stephan Nopp, and Florian Moik from the Department of Medicine I, Clinical Division of Haematology and Haemostaseology,...
In a systematic review of the worldwide published data on "Venous thromboembolism (VTE) in COVID-19 patients”, Cihan Ay, Stephan Nopp, and Florian Moik from the Department of Medicine I, Clinical Division of Haematology and Haemostaseology,...
In a systematic review of the...
10/01/2020
Vascular Disease Management
News
09/29/2020
Novel perfusion monitoring system injects new precision into the treatment of peripheral artery disease and critical limb ischemia.
Novel perfusion monitoring system injects new precision into the treatment of peripheral artery disease and critical limb ischemia.
Novel perfusion monitoring...
09/29/2020
Vascular Disease Management
News
09/24/2020
Powerfully simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system  Intuitive design eliminates the need for capital equipment, with easy setup supporting faster procedures...
Powerfully simple thrombectomy solution provides physicians with an all-in-one, single-use aspiration catheter and pump system  Intuitive design eliminates the need for capital equipment, with easy setup supporting faster procedures...
Powerfully simple thrombectomy...
09/24/2020
Vascular Disease Management

Advertisement

News
09/22/2020
First patient recruited into a trial of the BeGraft Plus as a bridging stent in BEVAR (branched endovascular aortic repair) for complex aortic aneurysms.
First patient recruited into a trial of the BeGraft Plus as a bridging stent in BEVAR (branched endovascular aortic repair) for complex aortic aneurysms.
First patient recruited into a...
09/22/2020
Vascular Disease Management
News
09/18/2020
BATON ROUGE—September 17, 2020—Dr. Niksad Abraham, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Baton Rouge to conduct a left- and right-sided heart procedure using Impella CP® and Impella RP®,...
BATON ROUGE—September 17, 2020—Dr. Niksad Abraham, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Baton Rouge to conduct a left- and right-sided heart procedure using Impella CP® and Impella RP®,...
BATON ROUGE—September 17,...
09/18/2020
Vascular Disease Management
News
09/18/2020
BUELACH, Switzerland - September 17, 2020—BIO4AMB Trial Results Demonstrate BIOTRONIK’s 4-French Portfolio to Be as Safe and Effective as 6-French Devices While Avoiding Additional Need of a Vascular Closure Device
BUELACH, Switzerland - September 17, 2020—BIO4AMB Trial Results Demonstrate BIOTRONIK’s 4-French Portfolio to Be as Safe and Effective as 6-French Devices While Avoiding Additional Need of a Vascular Closure Device
BUELACH, Switzerland - September...
09/18/2020
Vascular Disease Management

Advertisement

News
09/16/2020
BATON ROUGE— Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Niksad Abraham was the first to use the AMPLATZERTM Septal Occluder device for the closure of atrial septal defects at Baton Rouge General.
BATON ROUGE— Cardiovascular Institute of the South (CIS) interventional cardiologist Dr. Niksad Abraham was the first to use the AMPLATZERTM Septal Occluder device for the closure of atrial septal defects at Baton Rouge General.
BATON ROUGE— Cardiovascular...
09/16/2020
Vascular Disease Management
News
09/16/2020
Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrollment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch...
Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrollment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch...
Concept Medical Inc., focused on...
09/16/2020
Vascular Disease Management

Advertisement

News
09/14/2020
Abbott today announced the start of the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company's new Esprit™ BTK Everolimus Eluting Resorbable Scaffold System. This is the first Investigational Device Exemption (IDE)...
Abbott today announced the start of the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company's new Esprit™ BTK Everolimus Eluting Resorbable Scaffold System. This is the first Investigational Device Exemption (IDE)...
Abbott today announced the start...
09/14/2020
Vascular Disease Management

Advertisement